Research programme: AICARFT inhibitors - Agouron
Alternative Names: AICARFT inhibitors research programme - AgouronLatest Information Update: 16 Jun 1998
At a glance
- Originator Agouron Pharmaceuticals
- Class
- Mechanism of Action Aminoimidazolecarboxamide ribonucleotide formyltransferase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Inflammation
Most Recent Events
- 16 Jun 1998 Discontinued-Preclinical for Cancer in USA (Unknown route)
- 16 Jun 1998 Discontinued-Preclinical for Inflammation in USA (Unknown route)
- 17 Mar 1998 Preclinical development for Cancer in USA (Unknown route)